sábado, 14 de novembro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 27, 2025

XRP’s Historic December 2017 Surge Revisited—Could 2025 Set Up a Similar Move?

View original at finance.yahoo.com
XRP’s Historic December 2017 Surge Revisited—Could 2025 Set Up a Similar Move? Tsikhanovich Alena / Shutterstock.com Quick Read XRP rallied 1,200% in 6 weeks (December 2017): $0.25 to $3.30 driven by retail FOMO, exchange listings, Bitcoin hitting $20K…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Over 1.35 billion XRP tokens have been removed from circulation into long-term custody, representing 45% less supply available for sale

    80% confidence
  • Social media was flooded with 'XRP to $10' predictions during the 2017 rally

    80% confidence
  • A repeat of the 1,200% rally is possible in December 2025 if catalysts, sentiment, adoption, and structure align

    80% confidence
  • 2025 replaces retail mania with institutional firepower: $1.1B ETF inflows in 4 weeks, SEC settlement August 2025, RLUSD at $1B market cap

    80% confidence
  • XRP rallied 1,200% in 6 weeks from December 2017, driven by retail FOMO, exchange listings, and Bitcoin hitting $20K

    80% confidence
  • 2017 had zero institutional participation vs measured allocations in 2025; no regulatory clarity vs SEC settlement; pure speculation vs banks using ODL ($1.3B quarterly)

    80% confidence
  • Steady 50-100% gains could push XRP to $3-4 by mid-2026, or price could remain range-bound between $1.80-$2.50 as institutions accumulate slowly

    80% confidence

Data points we hold from this source

XRP · circulating supply reduction1.35 billion_tokens
XRP · stock price range1.80-2.20 USD
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,995
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,995 factos verificados com a fonte5,577 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
XRP’s Historic December 2017 Surge Revisited—Could 2025 Set Up a Similar Move? — Source | Via News | pt.VIA.NEWS